Avanos Medical (NYSE:AVNS) Releases Earnings Results, Beats Estimates By $0.03 EPS

Avanos Medical (NYSE:AVNS) released its earnings results on Wednesday. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03, Zacks reports. The company had revenue of $179.60 million during the quarter, compared to analyst estimates of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical updated its FY 2025 guidance to 1.050-1.250 EPS.

Avanos Medical Stock Performance

AVNS stock traded down $0.12 during mid-day trading on Friday, hitting $15.09. The company had a trading volume of 93,296 shares, compared to its average volume of 545,667. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm has a market cap of $693.54 million, a PE ratio of 44.38 and a beta of 0.98. Avanos Medical has a 12 month low of $14.40 and a 12 month high of $25.36. The stock’s fifty day moving average price is $16.12 and its two-hundred day moving average price is $19.67.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.